US FDA to remove controversial pedigree rule for unauthorised drug distributors
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is proposing to remove a controversial legislative provision that requires unauthorised wholesale distributors of prescription drugs to provide purchasers with a statement describing the product's chain of custody, or pedigree, dating as far back as to the manufacturer1.